AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
AMZN   2,410.39 (-0.47%)
NVDA   341.01 (-2.21%)
GE   7.29 (+7.21%)
TSLA   820.23 (+0.17%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
Log in

NASDAQ:MOTSMotus GI Stock Price, Forecast & News

$1.40
+0.10 (+7.69 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.30
Now: $1.40
$1.40
50-Day Range
$0.61
MA: $0.96
$1.26
52-Week Range
$0.46
Now: $1.40
$4.60
Volume137,462 shs
Average Volume146,449 shs
Market Capitalization$40.36 million
P/E RatioN/A
Dividend YieldN/A
Beta3.11
Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.
Read More
Motus GI logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.53 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MOTS
CUSIPN/A
Phone954-541-8000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$110,000.00
Book Value$0.44 per share

Profitability

Net Income$-23,090,000.00
Net Margins-17,405.97%

Miscellaneous

Employees44
Market Cap$40.36 million
Next Earnings Date8/14/2020 (Estimated)
OptionableNot Optionable

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Motus GI (NASDAQ:MOTS) Frequently Asked Questions

How has Motus GI's stock been impacted by COVID-19 (Coronavirus)?

Motus GI's stock was trading at $1.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MOTS shares have increased by 34.6% and is now trading at $1.40. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Motus GI?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Motus GI.

When is Motus GI's next earnings date?

Motus GI is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020. View our earnings forecast for Motus GI.

How were Motus GI's earnings last quarter?

Motus GI Holdings Inc (NASDAQ:MOTS) issued its quarterly earnings data on Thursday, May, 14th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.22) by $0.01. The business had revenue of $0.03 million for the quarter, compared to the consensus estimate of $0.15 million. Motus GI had a negative net margin of 17,405.97% and a negative return on equity of 148.97%. View Motus GI's earnings history.

What price target have analysts set for MOTS?

3 Wall Street analysts have issued 1 year price objectives for Motus GI's shares. Their forecasts range from $3.00 to $7.00. On average, they expect Motus GI's share price to reach $4.00 in the next year. This suggests a possible upside of 185.7% from the stock's current price. View analysts' price targets for Motus GI.

Has Motus GI been receiving favorable news coverage?

Media coverage about MOTS stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Motus GI earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutMotus GI.

Who are some of Motus GI's key competitors?

What other stocks do shareholders of Motus GI own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Motus GI investors own include Canopy Growth (CGC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Sorrento Therapeutics (SRNE), AT&T (T), Verizon Communications (VZ), Zynerba Pharmaceuticals (ZYNE), Heron Therapeutics (HRTX) and Netflix (NFLX).

Who are Motus GI's key executives?

Motus GI's management team includes the following people:
  • Mr. Timothy P. Moran, CEO & Director (Age 47)
  • Mr. Mark Pomeranz, Pres, COO & Director (Age 58)
  • Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 48)

When did Motus GI IPO?

(MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

Who are Motus GI's major shareholders?

Motus GI's stock is owned by many different retail and institutional investors. Top institutional shareholders include Trellus Management Company LLC (0.90%) and Alyeska Investment Group L.P. (0.55%). Company insiders that own Motus GI stock include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Larry N Feinberg, Life Sciences Maste Perceptive, Mark Pomeranz and Timothy P Moran. View institutional ownership trends for Motus GI.

Which institutional investors are selling Motus GI stock?

MOTS stock was sold by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P.. View insider buying and selling activity for Motus GI.

Which institutional investors are buying Motus GI stock?

MOTS stock was purchased by a variety of institutional investors in the last quarter, including Trellus Management Company LLC. Company insiders that have bought Motus GI stock in the last two years include Andrew Lawrence Taylor, David P Hochman, Gary E Jacobs, Larry N Feinberg, Life Sciences Maste Perceptive, Mark Pomeranz, and Timothy P Moran. View insider buying and selling activity for Motus GI.

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $1.40.

How big of a company is Motus GI?

Motus GI has a market capitalization of $40.36 million and generates $110,000.00 in revenue each year. The company earns $-23,090,000.00 in net income (profit) each year or ($0.92) on an earnings per share basis. Motus GI employs 44 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is www.motusgi.com.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 954-541-8000 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.